Author

Eleni Isidora Perdikouri

Observed names: Eleni I. Perdikouri, Eleni Isidora A. Perdikouri, Eleni-Isidora A. Perdikouri

Institutions: Aristotle University of Thessaloniki, AHEPA University Hospital

Observed institutions: Aristotle University of Thessaloniki, AHEPA University Hospital, Papageorgiou General Hospital, University Hospital of Larissa

OpenAlex ID: A5002201877

Infections Due to Multidrug-Resistant Bacteria in Oncological Patients: Insights from a Five-Year Epidemiological and Clinical Analysis

2019 · Eleni Isidora A. Perdikouri, Kostoula Arvaniti, et al. · Microorganisms · 57

Epithelial Ovarian Cancer: A Five Year Review

2023 · Christos Arnaoutoglou, Kalliopi Dampala, et al. · Medicina · 45

Cryo-Biopsy versus 19G needle versus 22G needle with EBUS-TBNA endoscopy

2022 · Rena Oikonomidou, Dimitris Petridis, et al. · Journal of Cancer · 11

A Real-World, Observational, Prospective Study to Assess the Molecular Epidemiology of Epidermal Growth Factor Receptor (EGFR) Mutations upon Progression on or after First-Line Therapy with a First- or Second-Generation EGFR Tyrosine Kinase Inhibitor in EGFR Mutation-Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer: The ‘LUNGFUL’ Study

2021 · Giannis Mountzios, Anna Koumarianou, et al. · Cancers · 9

Non-Small-Cell Lung Cancer Immunotherapy and Sleep Characteristics: The Crossroad for Optimal Survival

2023 · Paul Zarogoulidis, Dimitrios Petridis, et al. · Diseases · 8

Factors Affecting the Nuclei in Newborn and Children

2022 · Christos Arnaoutoglou, Anastasia Keivanidou, et al. · International Journal of Environmental Research and Public Health · 5

“One Shot” Sample Evaluation of 22G, 22G upgraded, 21G and 19G needle for Endobronchial Ultrasound-EBUS-TBNA

2022 · Rena Oikonomidou, Dimitris Petridis, et al. · Journal of Cancer · 3

Simultaneous Resection for Colorectal and Liver Metastases, new equipment and personalized medicine

2023 · Paul Zarogoulidis, Aris Ioannidis, et al. · Journal of Cancer · 2

Predictive and prognostic significance of PIOS (Patras Immunotherapy Score) model in patients with advanced NSCLC treated with nivolumab or pembrolizumab: Results from a validation cohort.

2021 · Foteinos-Ioannis D. Dimtrakopoulos, Giannis Socrates Mountzios, et al. · Journal of Clinical Oncology

Prognostication in non-small cell lung cancer.

2012 · Bruno Gagnon, Ioannis Gioulbasanis, et al. · Journal of Clinical Oncology

Works count: 10

Citation count: 140

H-index: 5

I10-index: 3